Rate this item
(0 votes)


By Super User 04 March, 2018 821

Manager of Operations. Eyal has joined the company in 2011. He is managing the company’s Supply chain, facilities and information systems. Eyal has brought to the company an extensive work experience of more than 10 years in various operations related positions. Prior to joining Immunovative Eyal was engaged as a production planner in the Industrial engineering department at Ophir Optronics. He has also led a manufacturing team in Intel Corporation. Eyal has a B.Sc. in Life Science from Ben-Gurion University and a M.Sc. in Technology Management from the Faculty of science and the Business School of the Hebrew University.


Last modified on Sunday, 04 March 2018 07:11



Treatment strategy designed to use the power of the human immune system to kill tumors and prevent their recurrence.
No requirement for a matched donor or chemotherapy/radiation conditioning prior to treatment.
Innovative technology – proven and non-toxic.
read more

Healthcare professionals

Therapeutic anti-tumor vaccine developed from core break-through technology called the "Mirror Effect™“ which opens a pathway to treating patients with metastatic cancer that have failed all available therapy options.
Elicits a GVT-like mechanism without the GVHD toxicity.
read more


Privately-held Israeli biopharmaceutical company spin out from Hadassah-Hebrew University Medical Center with headquarters in Jerusalem.

Over 200 individual private shareholders and grant support from the Israel Office of the Chief Scientist.
read more